AR031939A1 - Formulaciones de antibiotico de ionoforo - Google Patents

Formulaciones de antibiotico de ionoforo

Info

Publication number
AR031939A1
AR031939A1 ARP010105857A ARP010105857A AR031939A1 AR 031939 A1 AR031939 A1 AR 031939A1 AR P010105857 A ARP010105857 A AR P010105857A AR P010105857 A ARP010105857 A AR P010105857A AR 031939 A1 AR031939 A1 AR 031939A1
Authority
AR
Argentina
Prior art keywords
ionoforo
antibiotico
formulations
ionophore antibiotic
composition
Prior art date
Application number
ARP010105857A
Other languages
English (en)
Original Assignee
Eli Lilly & Company Nz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NZ509092A external-priority patent/NZ509092A/en
Application filed by Eli Lilly & Company Nz Ltd filed Critical Eli Lilly & Company Nz Ltd
Publication of AR031939A1 publication Critical patent/AR031939A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)

Abstract

La invencion se refiere a una composicion de antibiotico de ionoforo capaz de diluirse en agua hasta lograr una forma de dispersion sustancialmente estable en todo el agua presente, dicha composicion comprende o incluye: al menos un antibiotico de ionoforo (preferentemente monensin) de un tamano promedio de partícula de 20 micrones, - y al menos un agente de dispersion. También se divulga un método para preparar la composicion de un antibiotico ionoforo.
ARP010105857A 2000-12-19 2001-12-18 Formulaciones de antibiotico de ionoforo AR031939A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ509092A NZ509092A (en) 2000-12-19 2000-12-19 Ionophore antibiotic formulations containing a dispersing agent with the ionophore antibiotic having a mean particle size of less than 20 microns
NZ51418301 2001-09-13

Publications (1)

Publication Number Publication Date
AR031939A1 true AR031939A1 (es) 2003-10-08

Family

ID=26652236

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010105857A AR031939A1 (es) 2000-12-19 2001-12-18 Formulaciones de antibiotico de ionoforo

Country Status (12)

Country Link
US (2) US20040071782A1 (es)
EP (1) EP1345587B1 (es)
KR (1) KR20030078871A (es)
AR (1) AR031939A1 (es)
AT (1) ATE440591T1 (es)
AU (2) AU2002216503B9 (es)
BR (1) BRPI0116282B1 (es)
CA (1) CA2430791C (es)
DE (1) DE60139712D1 (es)
ES (1) ES2331406T3 (es)
MX (1) MXPA03005512A (es)
WO (1) WO2002049609A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2910323A1 (fr) * 2006-12-26 2008-06-27 Virbac Sa Sa Composition liquide anhydre destinee a etre incorporee a l'eau de boisson des animaux d'elevage.
US9149456B2 (en) * 2008-07-28 2015-10-06 Zoetis Services Llc Laidlomycin compositions and methods
US8415121B2 (en) * 2009-10-05 2013-04-09 Alpharma, Llc Process for the manufacture of laidlomycin
ES2948806T3 (es) 2015-02-17 2023-09-19 Univ Gent Forma de dosificación farmacéutica sólida adecuada para su uso como medicación en agua potable
EA033344B1 (ru) * 2015-04-28 2019-09-30 Эланко Юэс Инк. Водно-диспергируемые гранулы монензина, получаемые влажной грануляцией
KR102227147B1 (ko) * 2018-08-30 2021-03-12 한국화학연구원 이오노포어를 유효성분으로 포함하는 바이러스성 질환의 예방 또는 치료용 보조제

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754856A (fr) 1969-08-18 1971-02-15 Hoffmann La Roche Nouveaux antibiotiques
US3829557A (en) 1970-06-12 1974-08-13 Erco Ind Ltd Production of chlorine dioxide
US3839557A (en) * 1972-01-24 1974-10-01 Lilly Co Eli Antibiotics monensin and a204 for improving ruminant feed efficiency
IL70015A0 (en) 1983-10-20 1984-01-31 Koffolk 1949 Ltd Ionophore antibiotic compositions and processes for the preparation thereof
US4746349A (en) * 1986-08-06 1988-05-24 American Cyanamid Company Method and compositions for suppressing the nitrification of ammonium in plant growth medium
NZ272574A (en) * 1995-07-14 1999-02-25 Lilly Eli & Co Nz Ltd Aqueous base suspension concentrate containing at least one ionophore antibiotic and wetting agent and/or a surfactant and xanthan gum optionally with a suspension agent, an antifreeze agent and an antifoaming agent; drench for veterinary treatment
DE69632257T2 (de) * 1995-07-14 2005-04-28 Eli Lilly & Co. (Nz) Ltd., Manukau Formulierungen mit monensin
US6086633A (en) * 1996-10-17 2000-07-11 Eli Lilly And Company Method for preserving animal hides
AU715015B2 (en) * 1996-10-17 2000-01-13 Eli Lilly And Company Method for preserving animal hides
US6211185B1 (en) * 1999-05-05 2001-04-03 Veterinary Pharmacy Corporation Concentrate comprising a sulfonamide in solution, a 2,4-diaminopyrimidine in stable suspension within said solution, and a suspending agent

Also Published As

Publication number Publication date
AU2002216503B2 (en) 2006-04-27
AU1650302A (en) 2002-07-01
ES2331406T3 (es) 2010-01-04
KR20030078871A (ko) 2003-10-08
DE60139712D1 (de) 2009-10-08
MXPA03005512A (es) 2004-10-14
AU2002216503B9 (en) 2006-10-12
BRPI0116282B1 (pt) 2016-04-19
US20090238881A1 (en) 2009-09-24
BR0116282A (pt) 2004-03-02
CA2430791A1 (en) 2002-06-27
ATE440591T1 (de) 2009-09-15
WO2002049609A1 (en) 2002-06-27
US20040071782A1 (en) 2004-04-15
EP1345587A1 (en) 2003-09-24
CA2430791C (en) 2010-02-02
EP1345587B1 (en) 2009-08-26

Similar Documents

Publication Publication Date Title
CY1106015T1 (el) Ενα συμπυκνωμενο, υδατοδιαλυτο, κοκκωδες σκευασμα ρυθμιστη της φυτικης αναπτυξης και μεθοδοι χρησης και ιδιου
CA2338703A1 (en) Injectable aqueous dispersions of propofol
DE50114065D1 (de) Mit einer Hülle umgebene, dotierte Oxidpartikeln
CA2400317A1 (en) Improved paste formulations
BR0012908A (pt) Método para preparar uma composição oral estável antibacteriana contendo uma lupulona hidrogenada, e, composição oral estável antibacteriana
CA2212753A1 (en) Zinc oxide dispersions
BR0109091A (pt) Formulações de ranolazina de liberação sustentada
AU7119500A (en) Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
NZ335301A (en) Aqueous mycobacterial composition and hard surface disinfecting composition
ES2172915T3 (es) Formulaciones bucodentales que contienen nanofibrillas de celulosa esencialmente amorfas.
AU2002346396A1 (en) Compositions and kits comprising a defined boron compound, methods of their preparation, and use and administration thereof
AU2001289102A1 (en) Topical formulations for delivery of interleukin-11
BR0115952A (pt) Composição de emulsão para administração terapêutica, método de administração, processo para o preparo de uma formulação contendo derivados de fosfato de agentes de transferência de elétrons
WO2002015959A3 (en) Compounds and compositions for delivering active agents
AR031939A1 (es) Formulaciones de antibiotico de ionoforo
AU2001211213A1 (en) Stable oral formulation containing benzimidazole derivative
AU2001235783A1 (en) Therapeutic compositions for pulmonary delivery
PT961855E (pt) Dispersoes aquosas de um agente de colagem hidrofobo
ES2231176T3 (es) Uso de beta-(1,3)-glucanos nanometricos hidrosolubles.
WO2001070270A3 (en) Base compositions for preparing surfactant free topical compositions
ES2039621T3 (es) Agente de limpieza abrasivo acuoso espesado que no exhibe sineresis y metodo para su preparacion.
EP0976328A3 (en) Ectoparasite controlling agent for animals
AR011260A1 (es) Una composicion de dipersion de pigmento perlado universal suministrable mediante maquinas dispersadores, para ser usada en un recubrimiento de superficies y un metodo para prepararla
DE60012935D1 (de) Metalloxiddispersion
WO2004090062A3 (en) Lipid-soluble formulations containing mixtures of antioxidants

Legal Events

Date Code Title Description
FC Refusal